company background image
BAVA

Bavarian Nordic CPSE:BAVA Stock Report

Last Price

kr.220.40

Market Cap

kr.15.6b

7D

-8.8%

1Y

13.9%

Updated

30 Jan, 2023

Data

Company Financials +

BAVA Stock Overview

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines.

BAVA fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance0/6
Financial Health4/6
Dividends0/6

My Notes

New

Notes are coming soon

Bavarian Nordic A/S Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Bavarian Nordic
Historical stock prices
Current Share Pricekr.220.40
52 Week Highkr.411.00
52 Week Lowkr.115.20
Beta1.46
1 Month Change3.28%
3 Month Change-11.66%
1 Year Change13.90%
3 Year Change-8.17%
5 Year Change1.94%
Change since IPO-13.57%

Recent News & Updates

Is Bavarian Nordic (CPH:BAVA) Weighed On By Its Debt Load?

Jan 03
Is Bavarian Nordic (CPH:BAVA) Weighed On By Its Debt Load?

Recent updates

Is Bavarian Nordic (CPH:BAVA) Weighed On By Its Debt Load?

Jan 03
Is Bavarian Nordic (CPH:BAVA) Weighed On By Its Debt Load?

Bavarian Nordic (CPH:BAVA) Has Debt But No Earnings; Should You Worry?

Sep 15
Bavarian Nordic (CPH:BAVA) Has Debt But No Earnings; Should You Worry?

Rainbows and Unicorns: Bavarian Nordic A/S (CPH:BAVA) Analysts Just Became A Lot More Optimistic

Jul 24
Rainbows and Unicorns: Bavarian Nordic A/S (CPH:BAVA) Analysts Just Became A Lot More Optimistic

Industry Analysts Just Made A Notable Upgrade To Their Bavarian Nordic A/S (CPH:BAVA) Revenue Forecasts

Jun 14
Industry Analysts Just Made A Notable Upgrade To Their Bavarian Nordic A/S (CPH:BAVA) Revenue Forecasts

Analyst Forecasts Just Became More Bearish On Bavarian Nordic A/S (CPH:BAVA)

May 31
Analyst Forecasts Just Became More Bearish On Bavarian Nordic A/S (CPH:BAVA)

Is Bavarian Nordic (CPH:BAVA) Using Debt In A Risky Way?

May 06
Is Bavarian Nordic (CPH:BAVA) Using Debt In A Risky Way?

Bavarian Nordic A/S (CPH:BAVA) Analysts Just Cut Their EPS Forecasts Substantially

Mar 13
Bavarian Nordic A/S (CPH:BAVA) Analysts Just Cut Their EPS Forecasts Substantially

Health Check: How Prudently Does Bavarian Nordic (CPH:BAVA) Use Debt?

Oct 21
Health Check: How Prudently Does Bavarian Nordic (CPH:BAVA) Use Debt?

Calculating The Fair Value Of Bavarian Nordic A/S (CPH:BAVA)

Sep 16
Calculating The Fair Value Of Bavarian Nordic A/S (CPH:BAVA)

Health Check: How Prudently Does Bavarian Nordic (CPH:BAVA) Use Debt?

Jun 20
Health Check: How Prudently Does Bavarian Nordic (CPH:BAVA) Use Debt?

Is Bavarian Nordic A/S' (CPH:BAVA) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Mar 04
Is Bavarian Nordic A/S' (CPH:BAVA) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Estimating The Fair Value Of Bavarian Nordic A/S (CPH:BAVA)

Feb 06
Estimating The Fair Value Of Bavarian Nordic A/S (CPH:BAVA)

Here's Why Bavarian Nordic (CPH:BAVA) Can Manage Its Debt Responsibly

Jan 11
Here's Why Bavarian Nordic (CPH:BAVA) Can Manage Its Debt Responsibly

Here's Why We Don't Think Bavarian Nordic's (CPH:BAVA) Statutory Earnings Reflect Its Underlying Earnings Potential

Dec 21
Here's Why We Don't Think Bavarian Nordic's (CPH:BAVA) Statutory Earnings Reflect Its Underlying Earnings Potential

What Type Of Returns Would Bavarian Nordic's(CPH:BAVA) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Dec 01
What Type Of Returns Would Bavarian Nordic's(CPH:BAVA) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Shareholder Returns

BAVADK BiotechsDK Market
7D-8.8%-2.8%-1.3%
1Y13.9%20.6%7.2%

Return vs Industry: BAVA underperformed the Danish Biotechs industry which returned 26.5% over the past year.

Return vs Market: BAVA exceeded the Danish Market which returned 8.9% over the past year.

Price Volatility

Is BAVA's price volatile compared to industry and market?
BAVA volatility
BAVA Average Weekly Movement7.1%
Biotechs Industry Average Movement7.7%
Market Average Movement5.3%
10% most volatile stocks in DK Market12.3%
10% least volatile stocks in DK Market2.9%

Stable Share Price: BAVA is not significantly more volatile than the rest of Danish stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: BAVA's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1992917Paul Chaplinhttps://www.bavarian-nordic.com

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name. It is also developing MVA-BN (freeze-dried) that has completed Phase III clinical trials for the treatment of smallpox; MVA-BN RSV, which is in Phase III clinical trials for the treatment of respiratory syncytial virus; ABNCoV2 that has completed Phase II clinical trial for the treatment of SARS-CoV-2; and TAEK-VAC, which is in Phase I/II clinical trial for treatment of advanced HER2 and brachyury-expressing cancers.

Bavarian Nordic A/S Fundamentals Summary

How do Bavarian Nordic's earnings and revenue compare to its market cap?
BAVA fundamental statistics
Market Capkr.15.56b
Earnings (TTM)-kr.599.24m
Revenue (TTM)kr.2.40b

6.5x

P/S Ratio

-26.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
BAVA income statement (TTM)
Revenuekr.2.40b
Cost of Revenuekr.1.49b
Gross Profitkr.910.65m
Other Expenseskr.1.51b
Earnings-kr.599.24m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

Mar 02, 2023

Earnings per share (EPS)-8.49
Gross Margin37.88%
Net Profit Margin-24.92%
Debt/Equity Ratio12.8%

How did BAVA perform over the long term?

See historical performance and comparison